Genotype-Guided vs. Conventional P2Y12 Inhibitors in ACS | JACC: CV Interventions | JACC: Cardiovascular Interventions
Feb 13, 2026•7 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Mirza Umair Khalid, MD, Social Media Editor for JACC: Cardiovascular Interventions, and Mattio Galli, MD, PhD, discuss a recently published original research paper analyzing the role of genotype-guided escalation or de-escalation of antiplatelet therapy in acute coronary syndrome (ACS).
For the best experience, listen in Metacast app for iOS or Android